Pharmazie. 2008 Jun;63(6):411-4.

C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.

Source

Department of Orthopaedics, St. Vincent's Hospital, Peter MacCallum Cancer Centre, Melbourne, Australia. crispin.dass@svhm.org.au

Abstract

Recent studies have demonstrated the potential of DNAzymes for therapy of various diseases via mRNA target-specific cleavage. One such target, the basic region-leucine zipper protein c-Jun, has been targeted and efficacy seen in such pathologies as cancer, ocular neovascularisation, arterial thickening, acute inflammation, and rheumatoid arthritis. This review discusses these cases in turn, and presents some new data on the applicability of a c-jun DNAzyme against a panel of cancer cells. Importantly, downregulation of c-jun is noted to cause apoptotic death of cancer cells. These studies collectively demonstrate the potential of this DNAzyme as a lead candidate for DNAzyme therapeutics.

PMID:: 18604982; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity. [Oligonucleotides. 2006]
The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.
Rivory L, Tucker C, King A, Lai A, Goodchild A, Witherington C, Gozar MM, Birkett DJ. Oligonucleotides. 2006 Winter; 16(4):297-312.
Review DNAzyme technology and cancer therapy: cleave and let die. [Mol Cancer Ther. 2008]
Review DNAzyme technology and cancer therapy: cleave and let die.
Dass CR, Choong PF, Khachigian LM. Mol Cancer Ther. 2008 Feb; 7(2):243-51.
Review Preclinical anticancer activity of DNA-based cleavage molecules. [Drug Dev Ind Pharm. 2006]
Review Preclinical anticancer activity of DNA-based cleavage molecules.
Dass CR. Drug Dev Ind Pharm. 2006 Jan; 32(1):1-5.
Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme. [J Gastroenterol Hepatol. 2009]
Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.
Kumar D, Chaudhury I, Kar P, Das RH. J Gastroenterol Hepatol. 2009 May; 24(5):872-8. Epub 2009 Feb 9.
Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. [J Microencapsul. 2008]
Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
Dass CR, Friedhuber AM, Khachigian LM, Dunstan DE, Choong PF. J Microencapsul. 2008 Sep; 25(6):421-5.

See reviews... See all...

Cited by 1 PubMed Central article

Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours. [Cancer Cell Int. 2010]
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.
Tan ML, Choong PF, Dass CR. Cancer Cell Int. 2010 Mar 24; 10:9. Epub 2010 Mar 24.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
Pharmazie. 2008 Jun ;63(6):411-4.

PubMed
The activator protein-1 transcription factor in respiratory epithelium carcinoge...
The activator protein-1 transcription factor in respiratory epithelium carcinogenesis.
Mol Cancer Res. 2007 Feb ;5(2):109-20.

PubMed
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacki...
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver.
EMBO J. 2002 Apr 2 ;21(7):1782-90.

PubMed
c-jun is essential for normal mouse development and hepatogenesis.
c-jun is essential for normal mouse development and hepatogenesis.
Nature. 1993 Sep 9 ;365(6442):179-81.

PubMed
Vanishing vaccinations: why are so many Americans opting out of vaccinating thei...
Vanishing vaccinations: why are so many Americans opting out of vaccinating their children?
Univ Mich J Law Reform. 2004 Winter ;37(2):353-440.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: